Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 834528, 7 pages
http://dx.doi.org/10.1155/2014/834528
Research Article

P38 Plays an Important Role in Glucolipotoxicity-Induced Apoptosis in INS-1 Cells

Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing 100044, China

Received 1 October 2013; Revised 27 January 2014; Accepted 30 January 2014; Published 5 March 2014

Academic Editor: Yanbing Li

Copyright © 2014 Lingli Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Rhodes, “Type 2 diabetes—a matter of β-cell life and death?” Science, vol. 307, no. 5708, pp. 380–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, “β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes,” Diabetes, vol. 52, no. 1, pp. 102–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Y. Donath, J. A. Ehses, K. Maedler et al., “Mechanisms of β-cell death in type 2 diabetes,” Diabetes, vol. 54, supplement 2, pp. S108–S113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Karunakaran, H.-J. Kim, J.-Y. Kim, and I.-K. Lee, “Guards and culprits in the endoplasmic reticulum: glucolipotoxicity and β-cell failure in type II diabetes,” Experimental Diabetes Research, vol. 2012, Article ID 639762, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Poitout and R. P. Robertson, “Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. W. Kim and K. H. Yoon, “Glucolipotoxicity in pancreatic beta cells,” Diabetes & Metabolism Journal, vol. 35, no. 5, pp. 444–450, 2011. View at Google Scholar
  7. R. Lenin, M. S. Maria, M. Agrawal, J. Balasubramanyam, V. Mohan, and M. Balasubramanyam, “Amelioration of glucolipotoxicity-induced endoplasmic reticulum stress by a “chemical chaperone” in human THP-1 monocytes,” Experimental Diabetes Research, vol. 2012, Article ID 356487, 10 pages, 2012. View at Publisher · View at Google Scholar
  8. C. R. Weston, D. G. Lambright, and R. J. Davis, “MAP kinase signaling specificity,” Science, vol. 296, no. 5577, pp. 2345–2347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kaneto, T.-A. Matsuoka, Y. Nakatani, D. Kawamori, M. Matsuhisa, and Y. Yamasaki, “Oxidative stress and the JNK pathway in diabetes,” Current Diabetes Reviews, vol. 1, no. 1, pp. 65–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Yuan, X. Zhang, X. Huang et al., “NADPH oxidase 2-derived reactive oxygen species mediate FFAs-Induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways,” PLoS ONE, vol. 5, no. 12, Article ID e15726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Cheriyan, A. J. Webb, L. Sarov-Blat et al., “Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia,” Circulation, vol. 123, no. 5, pp. 515–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Y. Nowlin, M. J. Hammer, and G. D'Eramo Melkus, “Diet, inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 542698, 21 pages, 2012. View at Publisher · View at Google Scholar
  13. M. P. Stern, “Diabetes and cardiovascular disease: the “common soil” hypothesis,” Diabetes, vol. 44, no. 4, pp. 369–374, 1995. View at Google Scholar · View at Scopus
  14. A. G. Bertoni, G. L. Burke, J. A. Owusu et al., “Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA),” Diabetes Care, vol. 33, no. 4, pp. 804–810, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Astrup and N. Finer, “Redefining type 2 diabetes: “diabesity” or “obesity dependent diabetes mellitus”?” Obesity Reviews, vol. 1, no. 2, pp. 57–59, 2000. View at Google Scholar · View at Scopus
  16. D. Fang, H. Guan, J. Liu et al., “Early intensive insulin therapy attenuates the p38 pathway in the renal cortex and indices of nephropathy in diabetic rats,” Endocrine Journal, vol. 59, no. 1, pp. 81–90, 2012. View at Publisher · View at Google Scholar · View at Scopus